Displaying 69 Cambridge Health Tech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Qureight

Imaging analytics platform that processes and analyzes medical images.

42
$8M · Series A Ascension Ventures, Guinness Ventures, Hargreave Hale Aim VCT 1 to 10 Health Tech, Machine Learning, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@qureight.com
Fuse DiagnosticsJUST ADDED HIRING

Industrial diagnostic testing platform.

42
$2M · Seed Innovate UK 1 to 10 Health Tech B2B Cambridge, UK •••••••••••@fuse-dx.com
CMR Surgical

Surgical robotic system for minimal access surgery.

42
$164M · Series D SoftBank Group, Tencent, ABB Technology Ventures 501 to 1000 Health Tech, Robotics B2B Cambridge, UK •••••••••••@cmrsurgical.com
ieso

Transforming mental healthcare by unlocking the power of clinical data

37
$52M · Series B Molten Ventures 101 to 250 Health Tech, Deep Tech B2B, B2C Cambridge, UK •••••••••••@iesogroup.com
Sano Genetics

AI platform to advance precision medicine clinical trials.

37
$11M · Series A Seedcamp, Plural, Episode 1 11 to 50 Health Tech, Biotech B2B, SaaS Cambridge, UK •••••••••••@sanogenetics.com
NeoPhore

Small molecule neoantigen immuno-oncology therapies developer.

37
$12M · Series B Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management 1 to 10 Health Tech Cambridge, UK •••••••••••@neophore.com
Microbiotica

Human microbiome therapeutics developer creating live bacterial treatments and biomarkers.

37
$66M Seventure Partners, Cambridge Innovation Capital 11 to 50 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@microbiotica.com
ViaNautis

Drug delivery platform.

37
$24M · Series A 4BIO Capital, UCB Ventures, Business Growth Fund 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@vianautis.com
Healx

Platform for discovering new drugs for rare diseases using AI technology.

37
$56M · Series B Balderton Capital, Atomico, btov Partners 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Endomag

Medical technology improving breast cancer care through magnetic sensing innovations.

31
$20M · Series D Molten Ventures 51 to 100 Health Tech, Hardware B2B Cambridge, UK •••••••••••@endomag.com
Mogrify

Platform enabling the development of cell therapies through advanced reprogramming techniques.

31
$10M · Series A Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital 101 to 250 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@mogrify.co.uk
Supplant

"Biotechnology platform producing sugar substitutes."

31
$24M Khosla Ventures, Felicis Ventures, Y Combinator 11 to 50 Health Tech, Foodtech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@supplant.com
Metrion Biosciences

Contract Research Organization specializing in bioscience research services.

31
$4M · Series A Gresham House Ventures, NPIF Maven Equity Finance 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@metrionbiosciences.com
Broken String Biosciences

Genomics company building safer cell and gene therapies.

31
$15M · Series A Tencent, Illumina Ventures 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@brokenstringbio.com
Harness Therapeutics

Physiological upregulation therapy to treat neurodegenerative diseases.

31
$5M · Seed SV Health Investors 11 to 50 Health Tech, Biotech Cambridge, UK •••••••••••@harnesstx.com
bit.bio

Platform for understanding and defining the biological codes that make up human cells.

31
$41M · Series A Metaplanet Holdings, BlueYard Capital 101 to 250 Health Tech, Biotech, Deep Tech, Business Intelligence B2B Cambridge, UK •••••••••••@bit.bio
TidalSense

AI-driven tech for respiratory conditions.

26
$9M · Series A Business Growth Fund, Downing Ventures 11 to 50 Health Tech, AI Cambridge, UK •••••••••••@tidalsense.com
Mestag Therapeutics

Fibroblast technology designed to develop new therapies for diseases.

26
$11M · Seed GV, Forbion Capital Partners 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@mestagtx.com
Cydar Medical

Precision software for surgeries.

26
$11M · Series A Pembroke VCT 11 to 50 Health Tech B2B, SaaS Cambridge, UK •••••••••••@cydarmedical.com
Cake

Platform for helping people navigate end-of-life.

26
$14M Creandum, Headline 1 to 10 Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing B2C Cambridge, UK •••••••••••@joincake.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
PillSorted

Pharmacy service that combines caring customer support with modern technology for a personalized experience.

26
$6M · Seed Hoxton Ventures 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Ecommerce B2B, B2C, SaaS Cambridge, UK •••••••••••@pillsorted.com
PetMedix

Pet therapeutics startup dedicated to developing medicines for pets.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
Eagle Genomics

Platform that helps manage and analyze life sciences data for organizations.

26
$3M · Seed ETF Partners, Granpool Innovative Investments 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@eaglegenomics.com
Cyted

Cancer diagnostics.

26
$16M · Series A Business Growth Fund 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cyted.ai
MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

26
$6M · Series A Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments 51 to 100 Health Tech, Biotech Cambridge, UK •••••••••••@missiontherapeutics.com
Epitopea

Cancer immunotherapeutics company working across the Atlantic.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
Axol Bioscience

Live human cell cultures and genome editing services for researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
Artios Pharma

Independent biotech company focused on developing new cancer therapies targeting DNA damage response.

23
$152M · Series C 101 to 250 Health Tech, Deep Tech Cambridge, UK •••••••••••@artiospharma.com
Cambridge Epigenetix

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

23
$88M · Series D 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cambridge-epigenetix.com
Owlstone Medical

Breathalyzer technology for non-invasive detection of infectious diseases.

23
$57M · Series D 101 to 250 Health Tech Cambridge, UK •••••••••••@owlstonemedical.com
Semarion

Platform utilizing microfabrication technology to create smart materials for innovative cell testing.

21
$2M · Seed Parkwalk Advisors, Martlet Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@semarion.com
Sphere Fluidics

Platform specializing in single cell analysis and characterization, offering related R&D services.

21
$4M Sofinnova Partners 11 to 50 Health Tech, Deep Tech B2B Cambridge, UK •••••••••••@spherefluidics.com
Storm Therapeutics

Novel cancer therapies.

20
$30M · Series B 11 to 50 Health Tech, Deep Tech B2C Cambridge, UK •••••••••••@stormtherapeutics.com
PhoreMost

Drug discovery company based in Cambridge, UK.

20
$45M · Series B 1 to 10 Health Tech, Deep Tech Cambridge, UK •••••••••••@phoremost.com
Upfront Diagnostics

Clinical stage studies to discover biomarkers to improve medical diagnosis.

17
$2M · Seed 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@upfrontdiagnostics.com
Biofidelity HIRING

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

17
$940k · Seed Octopus Ventures, Longwall Venture, BlueYard Capital 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@biofidelity.com
Wren Therapeutics

Biopharmaceutical company focused on drug discovery and development for protein misfolding diseases.

17
$16M 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@wrentherapeutics.com
Transine Therapeutics

Platform for increasing protein production in the body using specialized translation enhancers.

17
$12M · Seed 11 to 50 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@transinetx.com
Charco Neurotech

Wearable device that offers non-invasive medical technology.

17
$692k · Pre Seed Amadeus Capital, Parkwalk Advisors 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@charconeurotech.com
CardiaTec Biosciences

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

17
$1M · Pre Seed LinkedIn 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@cardiatec.ai
Spotta

Smart pest control system provider.

17
$1M · Seed Martlet Capital 1 to 10 Health Tech, Manufacturing, Community & Lifestyle B2C Cambridge, UK •••••••••••@spotta.co
Healthera

Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.

17
$604k Innovate UK 11 to 50 Health Tech Cambridge, UK •••••••••••@healthera.co.uk
Phico Therapeutics

Platform technology overcoming antibacterial resistance.

17
$9M 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@phicotx.co.uk
Psyomics HIRING

AI-powered mental health assessment platform.

17
$5M · Series A Parkwalk Advisors, Martlet Capital 11 to 50 Health Tech, AI SaaS, B2C Cambridge, UK •••••••••••@psyomics.com
NRG Therapeutics

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

17
$18M 1 to 10 Health Tech, Biotech, Pharma B2B Cambridge, UK •••••••••••@nrgtherapeutics.com
SolasCure

Treatment for patients with chronic wounds.

17
$13M · Series B 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@solascure.com
PredictImmune

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

17
$7M · Series A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@predictimmune.com
Spirea Ltd.

Healthcare technology company improving patient care through innovative solutions.

14
$2M Health Tech Cambridge, UK •••••••••••@spirea.co.uk
Monocl

Platform for life science professionals to connect with global experts for strategic engagement.

14
$3M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@monocl.com
PharmEnable

Platform identifying chemical starting points to speed up drug discovery at lower costs.

14
$2M · Seed 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@pharmenable.com
Congenica

Diagnostic decision support platform for biotechnology applications.

12
N/A QVentures, Cambridge Innovation Capital, Parkwalk Advisors 11 to 50 Health Tech, Biotech, Genetics B2B Cambridge, UK •••••••••••@congenica.com
Decorte Future Industries

AI extracting health data from sound.

10
$585k · Pre Seed 1 to 10 Health Tech, Hardware, AI, Machine Learning, Manufacturing B2B Cambridge, UK •••••••••••@decorte.co.uk
52 North Health

Medical device-based system using AI to support clinical care for people with cancer.

10
$1M · Seed 1 to 10 Health Tech, Hardware, AI, Manufacturing B2B Cambridge, UK •••••••••••@52north.health
Legacy

A digital fertility clinic for men providing personalized care and services.

7
N/A 101 to 250 Health Tech, Biotech, Proptech & Real Estate, Femtech, Mobile, Energy & Nuclear, Genetics, Business Intelligence, Fertility B2B, SaaS Cambridge, UK •••••••••••@givelegacy.com
Revolo Biotherapeutics

Therapies designed to achieve long-term disease remission with less frequent doses.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@revolobio.com
Acacia Pharma

Molecular therapies for cancer patients.

4
N/A 11 to 50 Health Tech, Deep Tech B2C Cambridge, UK •••••••••••@acaciapharma.com
Antibodies.com

Supplier of protein research tools for scientific studies.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@antibodies.com
Bicycle Therapeutics

Platform for creating next-generation biotherapeutics.

4
N/A 101 to 250 Health Tech, Deep Tech Cambridge, UK •••••••••••@bicycletherapeutics.com
Cambridge Cancer Genomics

Platform offering precision oncology solutions to improve cancer treatment.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@ccg.ai
Crescendo Biologics

Platform for developing proprietary drugs using VH antibody fragments.

4
N/A 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@crescendobiologics.com
CS Genetics

Technology that advances genomics through innovative NGS techniques.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@csgenetics.com
Definigen

Human cell provider for drug discovery use in lead optimization and toxicity programs.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@definigen.com
Elpis BioMed

Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@elpis.ltd
Exonate

Biotech firm specializing in alternative splicing of VEGF for eye disease treatments.

4
N/A 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@exonate.com
F-star Biotechnology

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

4
N/A 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@f-star.com
Horizon Discovery

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

4
N/A 251 to 500 Health Tech, Deep Tech Cambridge, UK •••••••••••@horizondiscovery.com
Kirontech

Platform that uses machine learning to improve healthcare data utilization.

4
N/A 11 to 50 Health Tech, Data and Analytics Cambridge, UK •••••••••••@kirontech.com
Lab21

Lab 21 supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services.

4
N/A 51 to 100 Health Tech Cambridge, UK •••••••••••@lab21.com